SIGA Earnings Date: Nov 5, 2026 (Estimated) — SIGA Technologies, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is SIGA's next earnings date?
SIGA Technologies, Inc. (SIGA) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.
How did SIGA do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), SIGA Technologies, Inc. posted EPS of $0.17. Revenue was $41.0M. The stock's 1-day post-earnings move was -2.2%.
How much does SIGA stock move after earnings?
Over the last 8 reports the stock moved an average of 6.3% (up or down) in the day after earnings.
About SIGA Technologies, Inc.
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | — | 0.17 | — | $41.0M | — | -2.24% | -7.69% | +5.45% |
| 2026-05-07 | Q1 2026 | — | -0.05 | — | $6.2M | — | +1.48% | -9.94% | -8.46% |
| 2026-03-10 | Q4 2025 | — | -0.08 | — | $3.8M | — | -3.10% | -11.14% | -11.96% |
| 2025-11-06 | Q3 2025 | — | -0.09 | — | $2.6M | — | -19.95% | -25.58% | -24.73% |
| 2025-08-05 | Q2 2025 | — | 0.49 | — | $81.1M | — | +10.00% | +40.92% | +28.64% |
| 2025-03-11 | Q4 2024 | — | 0.63 | — | $81.4M | — | +6.96% | +2.85% | +8.74% |
| 2024-11-07 | Q3 2024 | — | 0.02 | — | $10.0M | — | -0.79% | -17.44% | -9.05% |
| 2024-08-01 | Q2 2024 | — | 0.03 | — | $21.8M | — | -5.85% | -0.66% | -2.28% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $41.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Product Sales and Supportive Services | 92.4% | $37.9M | -52.1% | $79.8M | $5.8M | $79.1M | $890K |
| Research and Development | 7.6% | $3.1M | +57.0% | $1.6M | $1.2M | $2.0M | $1.7M |
By region
Q2 FY26 · $54.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 51.9% | $28.0M | -65.4% | $70.3M | $1.2M | $81.1M | $2.6M |
| Non-US | 24.0% | $13.0M | — | $11.1M | $5.8M | — | — |
| Asia Pacific | 23.5% | $12.7M | — | $11.1M | — | — | — |
| EMEA | 0.5% | $273K | — | — | — | — | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.